BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33233721)

  • 21. Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma.
    Bouska A; Zhang W; Gong Q; Iqbal J; Scuto A; Vose J; Ludvigsen M; Fu K; Weisenburger DD; Greiner TC; Gascoyne RD; Rosenwald A; Ott G; Campo E; Rimsza LM; Delabie J; Jaffe ES; Braziel RM; Connors JM; Wu CI; Staudt LM; D'Amore F; McKeithan TW; Chan WC
    Leukemia; 2017 Jan; 31(1):83-91. PubMed ID: 27389057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of the cobas EZH2 mutation test on clinical samples from non-Hodgkin lymphoma patients.
    Shyu JY; Schlag PA; Karwowska SM; Manohar CF; Truong HM; Longshore JW; Zhang G
    PLoS One; 2023; 18(12):e0292251. PubMed ID: 38096164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.
    Borovecki A; Korać P; Nola M; Ivanković D; Jaksić B; Dominis M
    Croat Med J; 2008 Oct; 49(5):625-35. PubMed ID: 18925696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DZNep-mediated apoptosis in B-cell lymphoma is independent of the lymphoma type, EZH2 mutation status and MYC, BCL2 or BCL6 translocations.
    Akpa CA; Kleo K; Lenze D; Oker E; Dimitrova L; Hummel M
    PLoS One; 2019; 14(8):e0220681. PubMed ID: 31419226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiplex Droplet Digital PCR Quantification of Recurrent Somatic Mutations in Diffuse Large B-Cell and Follicular Lymphoma.
    Alcaide M; Yu S; Bushell K; Fornika D; Nielsen JS; Nelson BH; Mann KK; Assouline S; Johnson NA; Morin RD
    Clin Chem; 2016 Sep; 62(9):1238-47. PubMed ID: 27440511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genetic evolution of in situ follicular neoplasia to t(14;18)-positive aggressive B-cell lymphoma].
    Vogelsberg A; Steinhilber J; Mankel B; Federmann B; Schmidt J; Montes-Mojarro IA; Hüttl K; Rodriguez-Pinilla M; Baskaran P; Nahnsen S; Piris MA; Ott G; Quintanilla-Martinez L; Bonzheim I; Fend F
    Pathologe; 2021 Dec; 42(Suppl 2):122-128. PubMed ID: 34671837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCL2 mutations in diffuse large B-cell lymphoma.
    Schuetz JM; Johnson NA; Morin RD; Scott DW; Tan K; Ben-Nierah S; Boyle M; Slack GW; Marra MA; Connors JM; Brooks-Wilson AR; Gascoyne RD
    Leukemia; 2012 Jun; 26(6):1383-90. PubMed ID: 22189900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H3K27m3 overexpression as a new, BCL2 independent diagnostic tool in follicular and cutaneous follicle center lymphomas.
    Brune MM; Vela V; Bratic Hench I; Dertinger S; Borgmann V; Dirnhofer S; Tzankov A
    Virchows Arch; 2022 Sep; 481(3):489-497. PubMed ID: 35661922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines.
    Culpin RE; Proctor SJ; Angus B; Crosier S; Anderson JJ; Mainou-Fowler T
    Int J Oncol; 2010 Aug; 37(2):367-76. PubMed ID: 20596664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EZH2 mutations in follicular lymphoma from different ethnic groups and associated gene expression alterations.
    Guo S; Chan JK; Iqbal J; McKeithan T; Fu K; Meng B; Pan Y; Cheuk W; Luo D; Wang R; Zhang W; Greiner TC; Chan WC
    Clin Cancer Res; 2014 Jun; 20(12):3078-86. PubMed ID: 24634383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantifying the role of aberrant somatic hypermutation in transformation of follicular lymphoma.
    Halldórsdóttir AM; Frühwirth M; Deutsch A; Aigelsreiter A; Beham-Schmid C; Agnarsson BA; Neumeister P; Richard Burack W
    Leuk Res; 2008 Jul; 32(7):1015-21. PubMed ID: 18180034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EZH2 mutations are frequent and represent an early event in follicular lymphoma.
    Bödör C; Grossmann V; Popov N; Okosun J; O'Riain C; Tan K; Marzec J; Araf S; Wang J; Lee AM; Clear A; Montoto S; Matthews J; Iqbal S; Rajnai H; Rosenwald A; Ott G; Campo E; Rimsza LM; Smeland EB; Chan WC; Braziel RM; Staudt LM; Wright G; Lister TA; Elemento O; Hills R; Gribben JG; Chelala C; Matolcsy A; Kohlmann A; Haferlach T; Gascoyne RD; Fitzgibbon J
    Blood; 2013 Oct; 122(18):3165-8. PubMed ID: 24052547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma.
    Moore AM; Moshkin O; Swain GJ; Crocker S; LeBrun DP
    Diagn Pathol; 2018 May; 13(1):34. PubMed ID: 29793519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCL-6 mRNA expression in higher grade transformation of follicle center lymphoma: correlation with somatic mutations in the 5' regulatory region of the BCL-6 gene.
    Lossos IS; Warnke R; Levy R
    Leukemia; 2002 Sep; 16(9):1857-62. PubMed ID: 12200704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes.
    Lossos IS; Alizadeh AA; Diehn M; Warnke R; Thorstenson Y; Oefner PJ; Brown PO; Botstein D; Levy R
    Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8886-91. PubMed ID: 12077300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatic mutation of the 5' noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma.
    Szereday Z; Csernus B; Nagy M; László T; Warnke RA; Matolcsy A
    Am J Pathol; 2000 Mar; 156(3):1017-24. PubMed ID: 10702417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hitting back at lymphoma: How do modern diagnostics identify high-risk diffuse large B-cell lymphoma subsets and alter treatment?
    Abramson JS
    Cancer; 2019 Sep; 125(18):3111-3120. PubMed ID: 31287161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5' noncoding regulatory region of the BCL-6 gene.
    Lossos IS; Levy R
    Blood; 2000 Jul; 96(2):635-9. PubMed ID: 10887128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic evolution of
    Vogelsberg A; Steinhilber J; Mankel B; Federmann B; Schmidt J; Montes-Mojarro IA; Hüttl K; Rodriguez-Pinilla M; Baskaran P; Nahnsen S; Piris MA; Ott G; Quintanilla-Martinez L; Bonzheim I; Fend F
    Haematologica; 2021 Oct; 106(10):2673-2681. PubMed ID: 32855278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship of REL proto-oncogene to pathobiology and chemoresistance in follicular and transformed follicular lymphoma.
    Hu X; Baytak E; Li J; Akman B; Okay K; Hu G; Scuto A; Zhang W; Küçük C
    Leuk Res; 2017 Mar; 54():30-38. PubMed ID: 28095352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.